BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4200
-0.0268 (-6.00%)
At close: Aug 28, 2025, 4:00 PM
0.4400
+0.0200 (4.76%)
After-hours: Aug 28, 2025, 7:48 PM EDT

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $24.66 million. The enterprise value is $12.90 million.

Market Cap24.66M
Enterprise Value 12.90M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

BioAtla has 58.72 million shares outstanding. The number of shares has increased by 11.77% in one year.

Current Share Class 58.72M
Shares Outstanding 58.72M
Shares Change (YoY) +11.77%
Shares Change (QoQ) +0.44%
Owned by Insiders (%) 8.32%
Owned by Institutions (%) 14.25%
Float 45.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.18
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.17
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.24

Current Ratio 1.24
Quick Ratio 1.10
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -813.88% and return on invested capital (ROIC) is -353.86%.

Return on Equity (ROE) -813.88%
Return on Assets (ROA) -82.52%
Return on Invested Capital (ROIC) -353.86%
Return on Capital Employed (ROCE) -600.43%
Revenue Per Employee $180,328
Profits Per Employee -$975,656
Employee Count61
Asset Turnover 0.23
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -76.54% in the last 52 weeks. The beta is 0.89, so BioAtla's price volatility has been lower than the market average.

Beta (5Y) 0.89
52-Week Price Change -76.54%
50-Day Moving Average 0.38
200-Day Moving Average 0.59
Relative Strength Index (RSI) 58.47
Average Volume (20 Days) 572,244

Short Selling Information

The latest short interest is 4.44 million, so 7.56% of the outstanding shares have been sold short.

Short Interest 4.44M
Short Previous Month 3.92M
Short % of Shares Out 7.56%
Short % of Float 9.76%
Short Ratio (days to cover) 6.38

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$59.52 million in losses. Loss per share was -$1.11.

Revenue11.00M
Gross Profit -51.19M
Operating Income -63.22M
Pretax Income -104.56M
Net Income -59.52M
EBITDA -62.47M
EBIT -63.22M
Loss Per Share -$1.11
Full Income Statement

Balance Sheet

The company has $18.21 million in cash and $6.05 million in debt, giving a net cash position of $12.16 million or $0.21 per share.

Cash & Cash Equivalents 18.21M
Total Debt 6.05M
Net Cash 12.16M
Net Cash Per Share $0.21
Equity (Book Value) -16.75M
Book Value Per Share -0.29
Working Capital 4.01M
Full Balance Sheet

Cash Flow

Operating Cash Flow -52.32M
Capital Expenditures n/a
Free Cash Flow -52.32M
FCF Per Share -$0.89
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -574.72%
Pretax Margin -541.05%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.77%
Shareholder Yield -11.77%
Earnings Yield -237.47%
FCF Yield -208.77%

Analyst Forecast

The average price target for BioAtla is $1.00, which is 138.10% higher than the current price. The consensus rating is "Hold".

Price Target $1.00
Price Target Difference 138.10%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (5Y) 32.38%
EPS Growth Forecast (5Y) -7.38%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioAtla has an Altman Z-Score of -33.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -33.21
Piotroski F-Score 1